Papworth is the UK’s largest specialist cardiothoracic hospital and the country’s main heart / lung transplant centre. The Cystic Fibrosis Centre at Papworth provides specialist care to 300 adults, the majority of whom transition from paediatric CF services based in Cambridge and at Great Ormond Street Hospital in London. The Cambridge Centre for Lung Infection at Papworth Hospital (which incorporates the Adult Cystic Fibrosis Centre, the Bronchiectasis clinic and the Respiratory Immunology clinic) specialises in the diagnosis and treatment of difficult lung infection and has an excellent track record in recruiting patients to commercial and investigator-led novel therapy clinical trials involving patients with CF and non-CF bronchiectasis.

Charles Haworth is Director of the Cambridge Centre for Lung Infection at Papworth Hospital. He is a co-author of the North American CF Foundation, the UK CF Trust and European CF Society Bone Health Guidelines. He is co-chair of the North American CF Foundation / European Cystic Fibrosis Society working group on Non Tuberculous Mycobacterial infection and co-chair of the British Thoracic Society NTM guidelines committee. He is also a member of the BTS Bronchiectasis guidelines committee. He collaborates with several research groups at the University of Cambridge and has led a number of multicentre novel therapy clinical trials in CF and non-CF bronchiectasis. He is a member of the Cystic Fibrosis Foundation Data and Safety Monitoring Committee.

American CF Foundation Data and Safety Monitoring Board.

Andres Floto is a Welcome Trust Senior Fellow based at the Cambridge Institute of Medical Research at the University of Cambridge and is Director of Research at the Cambridge Centre for Lung Infection at Papworth Hospital. He has several successful collaborative basic science projects ongoing with research groups based in Europe, Australia and North America, as well as being Chief Investigator of two novel therapy clinical trials involving people with CF. He is co-chair of the North American CF Foundation / European Cystic Fibrosis Society working group on Non Tuberculous Mycobacterial infection and co-chair of the British Thoracic Society NTM guidelines development committee.